This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

IP and commericialisation - Steve May-Russell of - Smallfry - 17:59:49pm Jan-22nd

Universities and higher education institutions have a lot of IP trapped in their empires which is potentially quite lucrative – how do we help them understand that by working with us clever SMEs who are skilled and experienced in the commercialisation process, we all will benefit?

Agree/Disagree + add comment
 
 
t